Filtricine (Series A(+))
Funding Details
Company Info
Company Description
Filtricine, Inc. is a pre-clinical-stage therapeutic company. For cancer patients who want effective, safe, and long-lasting treatment, Filtricine is developing a drug-free cancer therapy based on nutrient deprivation. By precisely taking away the nutrients that are necessary only for cancer cells, the therapy kills only the cancer—not the patient.